Original reporting and analysis on the stories shaping biotech.
Abivax's oral Crohn's drug showed symptom relief in one week, while biologics typically take a month. Even wilder: preclinical data suggests it might also prevent the scar tissue that sends patients to surgery.
The Supreme Court killed IEEPA tariffs in a landmark 6-3 ruling, but pharma's supply chain headaches are just getting started. Section 232 duties on APIs and finished drugs survived, and with the U.S. importing 88% of its active ingredients from abroad, the real cost reckoning hasn't even begun.
Join thousands of biotech professionals who start their day with our free, daily briefing.